Carfilzomib (Kyprolis®) is a targeted therapy drug used to treat myeloma. It may sometimes be used to treat other cancers. It is best to read this information with our general information about targeted therapies and the type of cancer you have.
Carfilzomib is a type of targeted therapy called a proteasome inhibitor. Proteasomes work in cells to break down proteins that are no longer needed. Carfilzomib blocks the proteasomes so the proteins build up in the cell. This causes the cell to die.
Your doctor will talk to you about this treatment and its possible side effects before you agree (consent) to have treatment.